Current and future biomarkers in multiple sclerosis

J Yang, M Hamade, Q Wu, Q Wang, R Axtell… - International journal of …, 2022 - mdpi.com
Multiple sclerosis (MS) is a debilitating autoimmune disorder. Currently, there is a lack of
effective treatment for the progressive form of MS, partly due to insensitive readout for …

[HTML][HTML] Contribution of dysregulated B-cells and IgE antibody responses to multiple sclerosis

MR Seals, MM Moran, JD Leavenworth… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS), a debilitating autoimmune inflammatory disease that affects the
brain and spinal cord, causes demyelination of neurons, axonal damage, and …

[HTML][HTML] Biochemical biomarkers for multiple sclerosis

J Maroto-García, A Martínez-Escribano… - Clinica Chimica …, 2023 - Elsevier
Introduction Multiple sclerosis (MS) is the most frequent demyelinating disease of the central
nervous system. Although there is currently there is no definite cure for MS, new therapies …

Potential biomarkers associated with multiple sclerosis pathology

D Mathur, BK Mishra, S Rout, FJ Lopez-Iranzo… - International journal of …, 2021 - mdpi.com
Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS) that
involves an intricate and aberrant interaction of immune cells leading to inflammation …

Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-lines

FH Nazir, A Wiberg, M Müller, S Mangsbo… - Brain …, 2023 - academic.oup.com
Multiple sclerosis is a highly complex and heterogeneous disease. At the onset it often
presents as a clinically isolated syndrome. Thereafter relapses are followed by periods of …

Oligoclonal M bands unveil occult inflammation in multiple sclerosis

B Casanova, J Castillo, C Quintanilla-Bordás… - Multiple Sclerosis and …, 2022 - Elsevier
Introduction Recent works demonstrate that patients with multiple sclerosis (pwMS) and
oligoclonal M bands (OCMB) in cerebrospinal fluid (CSF) are at higher risk of conversion to …

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis

I Rosenstein, S Rasch, M Axelsson… - Frontiers in …, 2022 - frontiersin.org
Background Emerging evidence supports that determination of intrathecal immunoglobulin
M (IgM) synthesis (ITMS) and neurofilament light (NfL) concentration in cerebrospinal fluid …

Cerebrospinal fluid igm and oligoclonal igg bands in multiple sclerosis: A meta-analysis of prevalence and prognosis

M Fonderico, E Portaccio, L Razzolini, L Pastò… - Brain Sciences, 2021 - mdpi.com
The presence of intrathecal IgM synthesis (ITMS) has been associated with an aggressive
multiple sclerosis (MS) clinical course. In the present systematic review, we aimed at …

Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implications

E Ganelin-Cohen, S Shelly, Y Schiller… - Multiple Sclerosis and …, 2023 - Elsevier
Background Distinguishing between MOG-associated disease (MOGAD) and multiple
sclerosis (MS) presents a considerable challenge, as there are instances of overlapping …

High levels of cerebrospinal fluid kappa free light chains relate to IgM intrathecal synthesis and might have prognostic implications in relapsing multiple sclerosis

J Castillo-Villalba, S Gil-Perotín… - Frontiers in …, 2022 - frontiersin.org
Cerebrospinal kappa free light chain (KFLC)-index is a marker of intrathecal
immunoglobulin synthesis that aids in the diagnosis of multiple sclerosis (MS). However …